Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Cost of Revenue (2012 - 2021)

Updated

Analysis

Grace Therapeutics (GRCE) Cost of Revenue (2012 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 8.10 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 4.29 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 2.95 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 1.57 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 4.03 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 40,000.00
Dec 31, 2020 36,000.00
Nov 30, 2016 1.26 Mn
Feb 29, 2016 74,038.00
Nov 30, 2015 2,391.00
Aug 31, 2015 2,334.00
May 31, 2015 2,655.00
Feb 28, 2015 181,340.00
Nov 30, 2014 23,209.00
Aug 31, 2014 4,511.00
May 31, 2014 26,031.00
Feb 28, 2014 122,521.00
Nov 30, 2013 16,123.00
Aug 31, 2013 151,307.00
May 31, 2013 1,902.00
Feb 28, 2013 37,200.00
Nov 30, 2012 240,872.00
Aug 31, 2012 123,739.00
May 31, 2012 4,560.00
API Access

Grace Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=GRCE&period=max&api_key=YOUR_API_KEY